Faculty of Brain and Language Sciences, University College London, London, UK.
Anna Freud National Centre for Children and Families (AFNCCF), London, UK.
BMC Psychiatry. 2018 Nov 28;18(1):374. doi: 10.1186/s12888-018-1961-y.
Adolescence is a key period of risk for the emergence of Major Depressive Disorder (MDD). The prescription of selective serotonin re-uptake inhibitors (SSRIs) for the treatment of depression in adolescents is an issue of worldwide controversy, and evidence regarding their safety and efficacy is inconclusive. In the UK, NICE guidelines have recently recommended offering SSRIs to adolescents alongside psychological therapy or on their own if therapy is refused. Thus, SSRIs are increasingly becoming a major component of treatment for adolescents. This study qualitatively explored adolescents' views and experiences of SSRIs within their accounts of engaging in a psychological therapy for depression, particularly focusing on meanings they attached to medication-use.
The qualitative study reports data from semi-structured interviews conducted 12-months post-treatment with 12 adolescents who were clinically referred and treated for depression as part of the IMPACT trial. The interviews were analysed using Thematic Analysis.
Four themes were identified: 'a perceived threat to autonomy', 'a sign of severity', 'a support, not a solution', and 'an ongoing process of trial and error'.
This study highlights the value of bringing adolescents' voices into the broader debate on the use of antidepressants in their age group and in the development of future guidelines. Future implications for research and clinical practice are discussed.
青春期是出现重度抑郁症(MDD)的关键时期。在青少年中开具选择性 5-羟色胺再摄取抑制剂(SSRIs)治疗抑郁症是一个具有全球争议的问题,关于其安全性和疗效的证据尚无定论。在英国,NICE 指南最近建议,如果拒绝心理治疗,将 SSRIs 与心理治疗一起或单独提供给青少年。因此,SSRIs 越来越成为青少年治疗的主要组成部分。本研究通过对参与抑郁症心理治疗的青少年的叙述进行定性探索,重点关注他们对药物使用的看法,从而探究青少年对 SSRIs 的看法和体验。
本定性研究报告了 12 个月后进行的半结构化访谈的数据,共有 12 名青少年参与了这项研究,他们因抑郁而被临床转介并接受治疗,这是 IMPACT 试验的一部分。采用主题分析方法对访谈进行了分析。
确定了四个主题:“对自主权的感知威胁”、“严重程度的标志”、“支持,而不是解决办法”和“持续的试错过程”。
本研究强调了将青少年的声音纳入更广泛的关于在他们这个年龄段使用抗抑郁药的辩论以及未来指南制定的重要性。讨论了未来对研究和临床实践的影响。